The Trade Mission in Switzerland positions companies within a strategic European hub for genomics, where biobanks, translational research centers, and therapeutic precision clusters converge. The agenda facilitates connections with leading institutions in omic data integration, computational modeling, and personalized medicine platforms. This environment drives the development of solutions based on genetic analysis applied to targeted therapies and variant evaluation. Switzerland stands out for its advanced regulatory infrastructure and capacity to adopt disruptive technologies, favoring high value-added businesses.
